Asymmetric synthesis of homo-apioneplanocin A from d-ribose

Tetrahedron

Volumn 62, Issue 26, 2006, Pages 6339-6342

  Kim, Jin Hee ^a   Kim, Hea Ok ^b   Lee, Kang Man ^b   Chun, Moon Woo ^a   Moon, Hyung Ryong ^c   Jeong, Lak Shin ^b  

^a Seoul National University   (South Korea)

^b Ewha Womans University   (South Korea)

^c Pusan National University   (South Korea)

Author keywords

Chemoselective hydroboration; Chemoselective oxidation; Homo apioneplanocin A; Stereoselective hydroxymethylation

Indexed keywords

1 (2 HYDROXY)ETHYL 3 (ADENIN 9 YL) 4 CYCLOPENTENE 1,3 DIOL; 2,3 O ISOPROPYLIDENE 3 (2 HYDROXY)ETHYL 4 CYCLOPENTENOL; 2,3 O ISOPROPYLIDENE 3 (2 TRIPHENYLMETHYLOXY)ETHYL 4 CYCLOPENTENOL; 2,3 O ISOPROPYLIDENE 3 (2 TRIPHENYLMETHYLOXY)ETHYL 4 CYCLOPENTENOL 4 TOLUENESULFONATE; 2,3 O ISOPROPYLIDENE 3 VINYL 4 CYCLOPENTENOL; 3,4 O ISOPROPYLIDENE 3 (2 TRIPHENYLMETHYLOXY)ETHYL 5 (ADENIN 9 YL) CYCLOPENTENE; HOMOAPIONEPLANOCIN A; NEPLANOCIN A; RIBOSE; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; HYDROBORATION; METHYLATION; OXIDATION; PRIORITY JOURNAL; STEREOCHEMISTRY;

EID: 33646770349     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2006.04.042     Document Type: Article

References (27)

1. Yaginuma S., Muto N., Tsujino M., Sudate Y., Hayashi M., and Otani M. J. Antibiot. 34 (1981) 359-366
2. Borchardt R.T., Keller B.T., and Patel-Thombre U. J. Biol. Chem. 259 (1984) 4353-4358
3. De Clercq E. Antimicrob. Agents Chemother. 28 (1985) 84-89
4. Cools M., and De Clercq E. Biochem. Pharmacol. 38 (1989) 1061-1067
5. Glazer R.I., and Knode M.C. J. Biol. Chem. 259 (1984) 12964-12969
6. Inaba M., Nagashima K., Tsukagoshi S., and Sakurai Y. Cancer Res. 46 (1986) 1063-1067
7. De Clercq E., Murase J., and Marquez V. Biochem. Pharmacol. 41 (1991) 1821-1829
8. Shuto S., Obara T., Toriya M., Hosoya M., Snoeck R., Andrei G., Balzarini J., and De Clercq E. J. Med. Chem. 35 (1992) 324-331
9. Nair V., and Jahnke T.S. Antimicrob. Agents Chemother. 39 (1995) 1017-1029
10. Bamford M.J., Humber D.C., and Storer R. Tetrahedron Lett. 32 (1991) 271-274
11. Sells T.B., and Nair V. Tetrahedron Lett. 34 (1993) 3527-3530
12. Terao Y., Akamatsu M., and Achiwa K. Chem. Pharm. Bull. 39 (1991) 823-825
13. Jeong L.S., Lee Y.A., Moon H.R., and Chun M.W. Nucleosides Nucleotides 17 (1998) 1473-1487
14. Jeong L.S., Kim H.O., Moon H.R., Hong J.H., Yoo S.J., Choi W.J., Chun M.W., and Lee C.-K. J. Med. Chem. 44 (2001) 806-813
15. Moon H.R., Kim H.O., Lee K.M., Chun M.W., Kim J.H., and Jeong L.S. Org. Lett. 4 (2002) 3501-3503
16. Lee J.A., Moon H.R., Kim H.O., Kim K.R., Lee K.M., Kim B.T., Hwang K.J., Chun M.W., Jacobson K.A., and Jeong L.S. J. Org. Chem. 70 (2005) 5006-5013
17. Shuto S., Obara T., Saito Y., Andrei G., Snoeck R., De Clercq E., and Matsuda A. J. Med. Chem. 39 (1996) 2392-2399
18. Yang M., Schneller S.W., and Korba B. J. Med. Chem. 48 (2005) 5043-5046
19. Klimko, P. G.; Hellberg, M. R.; Falck, J. R.; Conrow, R. E. Preparation of hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders. U.S. Patent Appl. 35095, 2002, 34 pp.
20. Grubbs R.H., and Chang S. Tetrahedron 54 (1998) 4413-4450
21. Grubbs R.H. Tetrahedron 60 (2004) 7117-7140
22. Yasuike S., Kofink C.C., Kloetzing R.J., Gommermann N., Tappe K., Gavryushin A., and Knochel P. Tetrahedron: Asymmetry 16 (2005) 3385-3393
23. Widauer C., Grutzmacher H., and Ziegler T. Organometallics 19 (2000) 2097-2107
24. Mannig D., and Noth H. Angew. Chem., Int. Ed. Engl. 24 (1985) 878-879
25. Burgess K., and Ohlmeyer M.J. Chem. Rev. 91 (1991) 1179-1191
26. Evans D.A., Fu G.C., and Hoveyda A.H. J. Am. Chem. Soc. 114 (1992) 6671-6679
27. Naka T., Minakawa N., Abe H., Kaga D., and Matsuda A. J. Am. Chem. Soc. 122 (2000) 7233-7243